“Genetically reprogramming of B cells to enhance their therapeutic properties before autologous transfer”
The laboratory EVIR - Enveloped viruses, Vectors and Immunotherapy - at CIRI is welcoming applications from enthusiastic and independent post-doctoral candidates to continue research projects on the genetic reprogramming of B cells, aiming to trigger the expression of therapeutic molecules under regulation by in vivo sensing of diseases-specific signals. The overall goal is to validate an active immunotherapy strategy by targeting some chronic diseases (onco, infectious and inflammatory). This project includes both in vitro and in vivo experiments. The position is currently available and funded for 3 years.
Deadline for application: 31st December 2022.